vs
Lantheus Holdings, Inc.（LNTH）与ROYAL GOLD INC（RGLD）财务数据对比。点击上方公司名可切换其他公司
Lantheus Holdings, Inc.的季度营收约是ROYAL GOLD INC的1.1倍（$406.8M vs $375.3M），ROYAL GOLD INC净利率更高（24.9% vs 13.3%，领先11.6%），ROYAL GOLD INC同比增速更快（85.3% vs 4.0%），过去两年ROYAL GOLD INC的营收复合增速更高（58.8% vs 4.9%）
Lantheus Holdings是一家全球性医疗保健企业，专注于研发、生产及商业化创新诊断显像剂与相关解决方案，产品覆盖肿瘤学、心脏病学、泌尿学等核心医疗领域，主要市场遍及北美及全球其他重点地区。
Royal Gold Inc.是全球领先的贵金属流权与特许权经营企业，收购并管理多元化的矿业项目流权、净熔炼收益特许权及相关权益，资产覆盖黄金、白银、铜等品类，业务遍及多地区，无需直接承担采矿运营风险。
LNTH vs RGLD — 直观对比
营收规模更大
LNTH
是对方的1.1倍
$375.3M
营收增速更快
RGLD
高出81.3%
4.0%
净利率更高
RGLD
高出11.6%
13.3%
两年增速更快
RGLD
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $406.8M | $375.3M |
| 净利润 | $54.1M | $93.6M |
| 毛利率 | 59.2% | 64.6% |
| 营业利润率 | 19.0% | 56.2% |
| 净利率 | 13.3% | 24.9% |
| 营收同比 | 4.0% | 85.3% |
| 净利润同比 | 558.8% | -12.8% |
| 每股收益（稀释后） | $0.86 | $1.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LNTHRGLD
| Q4 25 | $406.8M | $375.3M | ||
| Q3 25 | $384.0M | $252.1M | ||
| Q2 25 | $378.0M | $209.6M | ||
| Q1 25 | $372.8M | $193.4M | ||
| Q4 24 | $391.1M | $202.6M | ||
| Q3 24 | $378.7M | $193.8M | ||
| Q2 24 | $394.1M | $174.1M | ||
| Q1 24 | $370.0M | $148.9M |
净利润LNTHRGLD
| Q4 25 | $54.1M | $93.6M | ||
| Q3 25 | $27.8M | $126.8M | ||
| Q2 25 | $78.8M | $132.3M | ||
| Q1 25 | $72.9M | $113.5M | ||
| Q4 24 | $-11.8M | $107.4M | ||
| Q3 24 | $131.1M | $96.2M | ||
| Q2 24 | $62.1M | $81.2M | ||
| Q1 24 | $131.1M | $47.2M |
毛利率LNTHRGLD
| Q4 25 | 59.2% | 64.6% | ||
| Q3 25 | 57.9% | 73.6% | ||
| Q2 25 | 63.8% | 72.6% | ||
| Q1 25 | 63.8% | 69.4% | ||
| Q4 24 | 63.5% | 70.3% | ||
| Q3 24 | 63.9% | 66.6% | ||
| Q2 24 | 64.9% | 64.7% | ||
| Q1 24 | 65.4% | 58.4% |
营业利润率LNTHRGLD
| Q4 25 | 19.0% | 56.2% | ||
| Q3 25 | 11.4% | 64.4% | ||
| Q2 25 | 23.3% | 67.7% | ||
| Q1 25 | 27.4% | 63.6% | ||
| Q4 24 | 29.1% | 65.9% | ||
| Q3 24 | 35.3% | 61.3% | ||
| Q2 24 | 26.1% | 58.6% | ||
| Q1 24 | 28.8% | 50.7% |
净利率LNTHRGLD
| Q4 25 | 13.3% | 24.9% | ||
| Q3 25 | 7.2% | 50.3% | ||
| Q2 25 | 20.8% | 63.1% | ||
| Q1 25 | 19.6% | 58.7% | ||
| Q4 24 | -3.0% | 53.0% | ||
| Q3 24 | 34.6% | 49.7% | ||
| Q2 24 | 15.8% | 46.6% | ||
| Q1 24 | 35.4% | 31.7% |
每股收益（稀释后）LNTHRGLD
| Q4 25 | $0.86 | $1.04 | ||
| Q3 25 | $0.41 | $1.92 | ||
| Q2 25 | $1.12 | $2.01 | ||
| Q1 25 | $1.02 | $1.72 | ||
| Q4 24 | $-0.18 | $1.63 | ||
| Q3 24 | $1.79 | $1.46 | ||
| Q2 24 | $0.88 | $1.23 | ||
| Q1 24 | $1.87 | $0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $359.1M | $233.7M |
| 总债务越低越好 | $568.7M | — |
| 股东权益账面价值 | $1.1B | $7.2B |
| 总资产 | $2.2B | $9.5B |
| 负债/权益比越低杠杆越低 | 0.52× | — |
8季度趋势，按日历期对齐
现金及短期投资LNTHRGLD
| Q4 25 | $359.1M | $233.7M | ||
| Q3 25 | $382.0M | $172.8M | ||
| Q2 25 | $695.6M | $248.2M | ||
| Q1 25 | $938.5M | $240.8M | ||
| Q4 24 | $912.8M | $195.5M | ||
| Q3 24 | $866.4M | $127.9M | ||
| Q2 24 | $757.0M | $74.2M | ||
| Q1 24 | $718.3M | $137.9M |
总债务LNTHRGLD
| Q4 25 | $568.7M | — | ||
| Q3 25 | $567.9M | — | ||
| Q2 25 | $566.8M | — | ||
| Q1 25 | $566.1M | — | ||
| Q4 24 | $565.3M | — | ||
| Q3 24 | $613.0K | $0 | ||
| Q2 24 | $563.2M | $50.0M | ||
| Q1 24 | $562.5M | — |
股东权益LNTHRGLD
| Q4 25 | $1.1B | $7.2B | ||
| Q3 25 | $1.1B | $3.4B | ||
| Q2 25 | $1.2B | $3.3B | ||
| Q1 25 | $1.2B | $3.2B | ||
| Q4 24 | $1.1B | $3.1B | ||
| Q3 24 | $1.2B | $3.0B | ||
| Q2 24 | $1.0B | $3.0B | ||
| Q1 24 | $945.5M | $2.9B |
总资产LNTHRGLD
| Q4 25 | $2.2B | $9.5B | ||
| Q3 25 | $2.3B | $4.5B | ||
| Q2 25 | $2.1B | $3.6B | ||
| Q1 25 | $2.1B | $3.5B | ||
| Q4 24 | $2.0B | $3.4B | ||
| Q3 24 | $2.0B | $3.3B | ||
| Q2 24 | $1.9B | $3.3B | ||
| Q1 24 | $1.8B | $3.3B |
负债/权益比LNTHRGLD
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 0.00× | 0.00× | ||
| Q2 24 | 0.55× | 0.02× | ||
| Q1 24 | 0.59× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $90.2M | $241.7M |
| 自由现金流经营现金流 - 资本支出 | $81.4M | — |
| 自由现金流率自由现金流/营收 | 20.0% | — |
| 资本支出强度资本支出/营收 | 2.2% | — |
| 现金转化率经营现金流/净利润 | 1.67× | 2.58× |
| 过去12个月自由现金流最近4个季度 | $354.1M | — |
8季度趋势，按日历期对齐
经营现金流LNTHRGLD
| Q4 25 | $90.2M | $241.7M | ||
| Q3 25 | $105.3M | $174.0M | ||
| Q2 25 | $87.1M | $152.8M | ||
| Q1 25 | $107.6M | $136.4M | ||
| Q4 24 | $157.7M | $141.1M | ||
| Q3 24 | $175.1M | $136.7M | ||
| Q2 24 | $84.7M | $113.5M | ||
| Q1 24 | $127.2M | $138.3M |
自由现金流LNTHRGLD
| Q4 25 | $81.4M | — | ||
| Q3 25 | $94.7M | — | ||
| Q2 25 | $79.1M | — | ||
| Q1 25 | $98.8M | — | ||
| Q4 24 | $141.4M | — | ||
| Q3 24 | $159.3M | — | ||
| Q2 24 | $73.5M | — | ||
| Q1 24 | $119.0M | — |
自由现金流率LNTHRGLD
| Q4 25 | 20.0% | — | ||
| Q3 25 | 24.7% | — | ||
| Q2 25 | 20.9% | — | ||
| Q1 25 | 26.5% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 42.0% | — | ||
| Q2 24 | 18.7% | — | ||
| Q1 24 | 32.2% | — |
资本支出强度LNTHRGLD
| Q4 25 | 2.2% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 4.2% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 2.2% | — |
现金转化率LNTHRGLD
| Q4 25 | 1.67× | 2.58× | ||
| Q3 25 | 3.79× | 1.37× | ||
| Q2 25 | 1.11× | 1.15× | ||
| Q1 25 | 1.47× | 1.20× | ||
| Q4 24 | — | 1.31× | ||
| Q3 24 | 1.34× | 1.42× | ||
| Q2 24 | 1.36× | 1.40× | ||
| Q1 24 | 0.97× | 2.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
RGLD
| Gold | $216.9M | 58% |
| Pueblo Viejo | $47.3M | 13% |
| Andacollo | $32.6M | 9% |
| Silver | $32.1M | 9% |
| Other | $27.2M | 7% |
| Copper | $13.7M | 4% |
| Cortez Legacy Zone | $5.4M | 1% |
